Arivale Closes $36M Series B Funding

Arivale_LogoArivale, a Seattle, WA-based provider of a scientific path to wellness for individuals, closed a $36m Series B funding round.

The round was led by ARCH Venture Partners and Polaris Partners, with participation from Maveron.

Based on the research of Lee Hood, MD, PhD, founder of the Seattle-based Institute for Systems Biology and led by Clayton Lewis, CEO and co-founder, Arivale uses science, personalized data (by looking at their genome, blood, saliva, gut microbiome and lifestyle data) and tailored coaching to deliver prioritized, actionable recommendations that inspire clients to achieve and sustain their wellness potential.
Initially launched in Seattle, the company will open in San Francisco in the fall –expanding into additional markets in 2016.

Arivale has also announced the formation of its Scientific Advisory Board (SAB), which will provide strategic guidance in systems biology, technology development, big data, analytics, translational medicine, behavioral science and nutrition. Members include:
– Frances Arnold, PhD, California Institute of Technology
– George Church, PhD, Harvard Medical School
– Robert C. Green, MD, MPH, Brigham and Women’s Hospital and Harvard Medical School
– Jim Heath, PhD, California Institute of Technology
– Lee Hood, MD, PhD, Institute for Systems Biology (chair)
– Ed Lazowska, PhD, University of Washington
– Larry Smarr, PhD, University of California, San Diego
– Ralph Snyderman, MD, Duke University
– Bonnie Spring, PhD, Northwestern University
– Eric Topol, MD, Scripps Research Institute



Join the discussion